Behcet's syndrome: Facts and controversies

被引:33
作者
Mat, Cem [1 ]
Yurdakul, Sebahattin [2 ]
Sevim, Aysegul [1 ]
Ozyazgan, Yilmaz [3 ]
Tuzun, Yalcin [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Med Fac, Dept Dermatol, TR-34098 Istanbul, Turkey
[2] Istanbul Univ, Dept Internal Med, Div Rheumatol, Cerrahpasa Med Fac, TR-34098 Istanbul, Turkey
[3] Istanbul Univ, Cerrahpasa Med Fac, Dept Ophthalmol, TR-34098 Istanbul, Turkey
关键词
DOUBLE-BLIND TRIAL; PATHERGY TEST; CLINICAL-FEATURES; PAPULOPUSTULAR LESIONS; SKIN HYPERREACTIVITY; INTERFERON ALPHA-2A; DISEASE; PREVALENCE; COLCHICINE; ARTHRITIS;
D O I
10.1016/j.clindermatol.2013.01.002
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Behcet's syndrome is a systemic vasculitis of small and large vessels affecting both veins and arteries. Almost all patients with Behcet's syndrome have recurrent oral aphthae, followed by genital ulcers, variable skin lesions, such as erythema nodosum and papulopustuler lesions, arthritis, uveitis, thrombophlebitis, and gastrointestinal and central nervous system involvement Recent epidemiologic works suggest that genetic factors are more important than environmental factors in its pathogenesis. European League Against Rheumatism guidelines were recently published for the treatment of Behcet's syndrome. Although these are quite useful for the management of mucocutaneous, eye, and joint involvement, treatment of vascular, neurological, and gastrointestinal involvement are still problematic as there are no controlled studies for these manifestations. This contribution addresses the epidemiology, mucocutaneous manifestations, diagnostic criteria, and evidence-based therapies, including biologic agents. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:352 / 361
页数:10
相关论文
共 93 条
[1]  
AKTULGA E, 1980, HAEMATOLOGICA, V65, P399
[2]   Neuro-Behcet's disease: epidemiology, clinical characteristics, and management [J].
Al-Araji, Adnan ;
Kidd, Desmond P. .
LANCET NEUROLOGY, 2009, 8 (02) :192-204
[3]   Clinical features and natural course of Behcet's disease in 661 cases: a multicentre study [J].
Alpsoy, E. ;
Donmez, L. ;
Onder, M. ;
Gunasti, S. ;
Usta, A. ;
Karincaoglu, Y. ;
Kandi, B. ;
Buyukkara, S. ;
Keseroglu, O. ;
Uzun, S. ;
Tursen, U. ;
Seyhan, M. ;
Akman, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (05) :901-906
[4]   The use of sucralfate suspension in the treatment of oral and genital ulceration of Behcet disease - A randomized, placebo-controlled, double-blind study [J].
Alpsoy, E ;
Er, H ;
Durusoy, C ;
Yilmaz, E .
ARCHIVES OF DERMATOLOGY, 1999, 135 (05) :529-532
[5]   Interferon alfa-2a in the treatment of Behcet disease - A randomized placebo-controlled and double-blind study [J].
Alpsoy, E ;
Durusoy, C ;
Yilmaz, E ;
Ozgurel, Y ;
Ermis, O ;
Yazar, S ;
Basaran, E .
ARCHIVES OF DERMATOLOGY, 2002, 138 (04) :467-471
[6]   A randomized, controlled and blinded study of papulopustular lesions in Turkish Behcet's patients [J].
Alpsoy, E ;
Aktekin, M ;
Er, H ;
Durusoy, C ;
Yilmaz, E .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1998, 37 (11) :839-842
[7]  
ALTAC M, 1982, ACTA DERM-VENEREOL, V62, P158
[8]  
AZIZLERLI G, 1992, ACTA DERM-VENEREOL, V72, P286
[9]  
Behçet H, 1937, DERMATOL WOCHENSCHR, V105, P1152
[10]  
BEHCET H, 1938, DERI HASTALIKLARI FR, V5, P1863